SANGAMO THERAPEUTICS INC's ticker is and the CUSIP is 800677956. A total of 4 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 300 | -99.3% | 0.00% | – |
| Q2 2023 | $58 | +65.7% | 45,200 | +126.0% | 0.00% | – |
| Q1 2023 | $35 | -61.1% | 20,000 | -30.6% | 0.00% | – |
| Q4 2022 | $90 | -99.9% | 28,800 | -19.1% | 0.00% | – |
| Q3 2022 | $174,000 | +42.6% | 35,600 | +20.3% | 0.00% | – |
| Q2 2022 | $122,000 | +149.0% | 29,600 | +248.2% | 0.00% | – |
| Q1 2022 | $49,000 | -82.2% | 8,500 | -77.0% | 0.00% | – |
| Q4 2021 | $276,000 | -30.3% | 36,900 | +11.8% | 0.00% | – |
| Q3 2021 | $396,000 | +2.9% | 33,000 | +2.5% | 0.00% | – |
| Q2 2021 | $385,000 | – | 32,200 | +11003.4% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 290 | -63.8% | 0.00% | -100.0% |
| Q4 2020 | $1,249,000 | +165.2% | 801 | +60.5% | 0.00% | +100.0% |
| Q3 2020 | $471,000 | -37.9% | 499 | -41.1% | 0.00% | 0.0% |
| Q2 2020 | $758,000 | +38.6% | 847 | -1.4% | 0.00% | 0.0% |
| Q1 2020 | $547,000 | -29.8% | 859 | -7.7% | 0.00% | -50.0% |
| Q4 2019 | $779,000 | +8.5% | 931 | +17.3% | 0.00% | 0.0% |
| Q3 2019 | $718,000 | +43.0% | 794 | +70.0% | 0.00% | +100.0% |
| Q2 2019 | $502,000 | -20.9% | 467 | -29.9% | 0.00% | -50.0% |
| Q1 2019 | $635,000 | -24.3% | 666 | -8.9% | 0.00% | 0.0% |
| Q4 2018 | $839,000 | -68.5% | 731 | -53.5% | 0.00% | -77.8% |
| Q3 2018 | $2,662,000 | +349.7% | 1,571 | +276.7% | 0.01% | +350.0% |
| Q2 2018 | $592,000 | +40.6% | 417 | -21.5% | 0.00% | -89.5% |
| Q1 2018 | $421,000 | +1813.6% | 531 | +382.7% | 0.02% | +1800.0% |
| Q4 2017 | $22,000 | +340.0% | 110 | +1.9% | 0.00% | – |
| Q3 2017 | $5,000 | -83.3% | 108 | -62.1% | 0.00% | -100.0% |
| Q2 2017 | $30,000 | -6.2% | 285 | -46.1% | 0.00% | 0.0% |
| Q1 2017 | $32,000 | -42.9% | 529 | +209.4% | 0.00% | -66.7% |
| Q4 2016 | $56,000 | +24.4% | 171 | -36.4% | 0.00% | 0.0% |
| Q3 2016 | $45,000 | +12.5% | 269 | +15.9% | 0.00% | 0.0% |
| Q2 2016 | $40,000 | -42.0% | 232 | +78.5% | 0.00% | -50.0% |
| Q1 2016 | $69,000 | -1.4% | 130 | -61.8% | 0.01% | +20.0% |
| Q4 2015 | $70,000 | +89.2% | 340 | +871.4% | 0.01% | +66.7% |
| Q3 2015 | $37,000 | -7.5% | 35 | -87.9% | 0.00% | -40.0% |
| Q1 2015 | $40,000 | +233.3% | 290 | +27.8% | 0.01% | +400.0% |
| Q4 2014 | $12,000 | – | 227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 81,161 | $932,000 | 0.20% |
| GROUP ONE TRADING, L.P. | 112,100 | $1,287,000 | 0.01% |
| SIMPLEX TRADING, LLC | 731 | $839,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 30,000 | $344,000 | 0.00% |